Related Experiment Video
Updated: May 11, 2026

10:58
TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism
Published on: December 28, 2010
17.6K
Exploring Photobiomodulation as a Potential Novel Intervention for Developmental Stuttering: A Review and Hypothesis
Borja Ignacio Ferreras1,2, Manuela Goyeneche3, Paolo Cassano1,2
1Division of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital, Boston, MA 02114, USA.
Journal of Clinical Medicine
|March 14, 2026
Summary
Transcranial photobiomodulation (t-PBM) may offer new hope for developmental stuttering (DS). This non-invasive therapy targets brain function deficits associated with DS, potentially improving speech fluency.
Area of Science:
- Neuroscience
- Neuromodulation
- Speech-Language Pathology
Background:
- Developmental stuttering (DS) is a complex neurodevelopmental disorder impacting speech fluency in ~5% of children.
- Current interventions for DS have variable long-term efficacy, and its pathophysiology is not fully understood.
- DS is linked to reduced cerebral blood flow, mitochondrial dysfunction, and impaired neural connectivity.
Purpose of the Study:
- To evaluate the therapeutic potential of transcranial photobiomodulation (t-PBM) for developmental stuttering (DS).
- To review t-PBM's mechanisms of action in relation to the neurophysiological deficits observed in DS.
- To explore t-PBM as a potential intervention for DS.
Main Methods:
- This study is a scoping review.
- It summarizes existing evidence on t-PBM mechanisms.
- It correlates t-PBM's effects with known neurophysiological deficits in DS.
Main Results:
- t-PBM may enhance cerebral blood flow by stimulating ATP production and vasodilation.
- t-PBM can promote neuroplasticity and modulate astrocyte function.
- The technique may also reduce anxiety associated with DS.
Conclusions:
- t-PBM shows theoretical promise as a low-risk intervention for DS.
- Clinical trials are necessary to confirm its therapeutic utility and efficacy.
- Optimizing treatment parameters and exploring combination therapies are future research directions.

